サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1463716

アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査：2030年までの市場予測 - 地域分析 - 検査タイプ、技術、流通チャネル別

Asia Pacific Direct-to-Consumer Genetic Testing Market Forecast to 2030 - Regional Analysis - by Test Type, Technology, and Distribution Channel

出版日
ページ情報
英文 78 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査：2030年までの市場予測 - 地域分析 - 検査タイプ、技術、流通チャネル別
出版日: 2024年02月07日
発行: The Insight Partners
ページ情報: 英文 78 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場は、2022年に3億5,424万米ドルと評価され、2030年には15億3,084万米ドルに達すると予測され、2022年から2030年までのCAGRは20.1%で成長すると推定されます。

一塩基多型（SNP）チップの採用拡大がアジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場を後押し

近年、科学的知識の増加に伴い、伝統的医療から個別化医療へのパラダイムシフトが着実に進んでいます。このシフトは、遺伝子工学の進歩、一塩基多型（SNP）ジェノタイピング、マイクロアレイとバイオチップ技術の高い採用によるものです。何十万ものSNPを持つ遺伝子マイクロアレイ分析プラットフォームのイントロダクションは、より奥まった系譜関係を個人間でよりオープンに検査するための高度なアルゴリズムの導入を促すと思われます。さらに、悪性腫瘍の検出に対する需要も高まっています。小児科領域では、SNP変異を大量の欠失にハイブリダイズする必要がなく、短時間で結果が得られることが膨大な需要につながっています。その結果、より多くの遺伝子異常が検出され、治療されるようになり、市場は成長すると予想されます。

高い効率と精度を持つSNPチップは、技術的に高度でより洗練されたDTC遺伝子検査への絶え間ないニーズにより、需要の増加を目の当たりにしています。SNPチップに対する高い嗜好性は、がん研究に不可欠なSNPマイクロアレイ解析のような様々なアプリケーションとともに、投与量変化やDNA多型を測定するその能力に起因しています。さらに、DTC遺伝子検査におけるエラーを最小限に抑える必要性の高まりが、SNP技術の採用を促進し、それによって市場成長の機会を提供すると予想されます。

アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場概要

アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に細分化されます。この地域の市場は、予測期間中、世界の主要地域の中で最も速いペースで成長すると予想されます。アジア太平洋地域におけるDTC（Direct-To-Consumer）遺伝子検査市場の普及は、優れた治療ソリューションに対するニーズの高まり、遺伝性疾患の早期スクリーニングに対する意識の高まり、研究開発活動への注力の高まりに起因しています。さらに、ゲノミクスのための研究開発の急増、多くの患者プール、ヘルスケアインフラのアップグレードは、予測期間中、アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場の成長に有利に働くと予測されています。

アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場の収益と2030年までの予測（金額）

アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場のセグメンテーション

アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場は、検査タイプ、技術、流通チャネル、国に区分されます。

検査タイプに基づき、アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場は、祖先検査、予測検査、ニュートリゲノミクス検査、キャリア検査、その他に区分されます。2022年には家系検査市場セグメントが最大のシェアを占めました。

技術面では、アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場は、全ゲノムシークエンシング、一塩基多型チップ、標的分析、その他に分類されます。一塩基多型チップセグメントは2022年に最大のシェアを占めました。

アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場は、販売チャネルに基づいてオンラインとオフラインに二分されます。オンラインセグメントが2022年に大きなシェアを占めました。

国別では、アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。中国は2022年にアジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場を独占しました。

Genesis Healthcare Co.、Ancestry Genomics Inc.、Myriad Genetics, Inc.、Living DNA Ltd.、23andMe Inc.、Genetic Technologies Ltd.は、アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場で事業を展開している主要企業の一部です。

目次

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場情勢

第5章 アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場-主要産業力学

  • 市場促進要因
    • 遺伝性疾患の発生率の増加
    • 遺伝子検査の潜在的利益に関する意識の高まり
  • 市場抑制要因
    • DTC（Direct-To-Consumer）遺伝子検査に関連する高コストとプライバシーの懸念
  • 市場機会
    • 一塩基多型（SNP）チップの採用拡大
  • 今後の動向
    • 薬理遺伝学への関心の高まりとテレヘルスの採用増加
  • 影響分析

第6章 DTC（Direct-To-Consumer）遺伝子検査市場-アジア太平洋地域市場分析

  • アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場収益、2022年～2030年

第7章 アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場 - 収益と2030年までの予測：検査タイプ別

  • 市場収益シェア、2022年および2030年
  • 家系検査
  • ニュートリゲノミクス検査
  • 予測検査
  • キャリア検査
  • その他

第8章 アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場 - 収益と2030年までの予測：技術別

  • 市場収益シェア、2022年および2030年
  • 全ゲノムシーケンス
  • 一塩基多型チップ
  • ターゲット分析
  • その他

第9章 アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場 - 収益と2030年までの予測：流通チャネル別

  • 市場収益シェア、2022年および2030年
  • オンラインプラットフォーム
  • オフラインプラットフォーム

第10章 アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場 - 収益と2030年までの予測：国別分析

  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他の国

第11章 アジア太平洋地域のDTC（Direct-To-Consumer）遺伝子検査市場-業界情勢

  • 有機的開発
  • 無機的展開

第12章 企業プロファイル

  • Genesis Healthcare Co
  • Ancestry Genomics Inc
  • Myriad Genetics, Inc.
  • Living DNA Ltd
  • 23andMe Inc
  • Genetic Technologies Ltd

第13章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Direct-to-Consumer Genetic Testing Market Segmentation
  • Table 2. China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel- Revenue and Forecast to 2030 (US$ Million)
  • Table 8. India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel- Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Organic Developments Done by Companies
  • Table 21. Inorganic Developments Done by Companies
  • Table 22. Glossary of Terms, Asia Pacific Direct-to-Consumer Genetic Testing Market

List Of Figures

  • Figure 1. Asia Pacific Direct-to-Consumer Genetic Testing Market Segmentation, By Country
  • Figure 2. Asia Pacific Direct-to-Consumer Genetic Testing Market: Key Industry Dynamics
  • Figure 3. Asia Pacific Direct-to-Consumer Genetic Testing Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 6. Ancestry Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Nutrigenomics Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Predictive Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Carrier Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 12. Whole Genome Sequencing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Single Nucleotide Polymorphism Chips: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Targeted Analysis: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 17. Online Platform: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Offline Platform: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Asia Pacific Direct-to-Consumer Genetic Testing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 20. Asia Pacific Direct-to-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
  • Figure 21. China: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. India: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
目次
Product Code: BMIRE00029624

The Asia Pacific direct-to-consumer genetic testing market was valued at US$ 354.24 million in 2022 and is expected to reach US$ 1,530.84 million by 2030; it is estimated to grow at a CAGR of 20.1% from 2022 to 2030.

Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips Fuels the Asia Pacific Direct-to-Consumer Genetic Testing Market

There has been a steady paradigm shift from traditional medicine to personalized medicine with increasing scientific knowledge in recent years. This shift is due to advances in genetic engineering, single nucleotide polymorphism (SNP) genotyping, and the high adoption of microarrays and biochip technologies. The introduction of genetic microarray analysis platforms with hundreds of thousands of SNPs will encourage the implementation of advanced algorithms to test for more secluded genealogical relationships more openly between individuals. In addition, the demand for detecting malignant tumors has also increased. In the pediatric field, the short turnaround time without the need to hybridize SNP variations to massive deletions has led to enormous demand. As a result, the market is expected to grow as more genetic abnormalities are detected and treated.

SNP chips with high efficiency and accuracy are witnessing an increase in demand due to the constant need for technologically advanced and more sophisticated DTC genetic testing. A high preference for SNP chips can be attributed to their ability to measure dosage changes and DNA polymorphism, along with various applications such as the SNP microarray analysis that are vital for cancer research. Furthermore, an increasing need to minimize errors in DTC genetic testing is expected to drive the adoption of SNP technology, thereby providing an opportunity for the market growth.

Asia Pacific Direct-to-Consumer Genetic Testing Market Overview

The Asia Pacific direct-to-consumer genetic testing market is sub segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market in this region is expected to grow at the fastest pace among all major regions in the world during the forecast period. The proliferation of the direct-to-consumer genetic testing market in Asia Pacific is attributed to the increasing need for superior treatment solutions, a rise in awareness of the early screening of genetic disorders, and the growing focus on research and development activities. Additionally, an upsurge in the R&D for genomics, a large pool of patients, and upgrades in healthcare infrastructure are projected to favor the growth of the direct-to-consumer genetic testing market in Asia Pacific during the forecast period.

Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Direct-to-Consumer Genetic Testing Market Segmentation

The Asia Pacific direct-to-consumer genetic testing market is segmented into test type, technology, distribution channel, and country.

Based on test type, the Asia Pacific direct-to-consumer genetic testing market is segmented into ancestry testing, predictive testing, nutrigenomics testing, carrier testing, and others. The ancestry testing market segment held the largest share in 2022.

In terms of technology, the Asia Pacific direct-to-consumer genetic testing market is categorized into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held the largest share in 2022.

Based on distribution channel, the Asia Pacific direct-to-consumer genetic testing market is bifurcated into online and offline. The online segment held a larger share in 2022.

Based on country, the Asia Pacific direct-to-consumer genetic testing market is segmented China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific direct-to-consumer genetic testing market in 2022.

Genesis Healthcare Co, Ancestry Genomics Inc, Myriad Genetics, Inc., Living DNA Ltd, 23andMe Inc, and Genetic Technologies Ltd are some of the leading companies operating in the Asia Pacific direct-to-consumer genetic testing market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Direct-to-Consumer Genetic Testing Market Landscape

  • 4.1 Overview

5. Asia Pacific Direct-to-Consumer Genetic Testing Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Incidence of Genetic Disorders
    • 5.1.2 Increasing Awareness About Potential Benefits of Genetic Testing
  • 5.2 Market Restraints
    • 5.2.1 High Cost and Privacy Concerns Associated With Direct-to-Consumer Genetic Testing
  • 5.3 Market Opportunities
    • 5.3.1 Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips
  • 5.4 Future Trends
    • 5.4.1 Growing Interest in Pharmacogenetics and Increasing Adoption of Telehealth
  • 5.5 Impact Analysis

6. Direct-to-Consumer Genetic Testing Market - Asia Pacific Market Analysis

  • 6.1 Overview
  • 6.2 Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 Ancestry Testing
    • 7.3.1 Overview
    • 7.3.2 Ancestry Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Nutrigenomics Testing
    • 7.4.1 Overview
    • 7.4.2 Nutrigenomics Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Predictive Testing
    • 7.5.1 Overview
    • 7.5.2 Predictive Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Carrier Testing
    • 7.6.1 Overview
    • 7.6.2 Carrier Testing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Whole Genome Sequencing
    • 8.3.1 Overview
    • 8.3.2 Whole Genome Sequencing: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Single Nucleotide Polymorphism Chips
    • 8.4.1 Overview
    • 8.4.2 Single Nucleotide Polymorphism Chips: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Targeted Analysis
    • 8.5.1 Overview
    • 8.5.2 Targeted Analysis: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 Asia Pacific Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Online Platform
    • 9.3.1 Overview
    • 9.3.2 Online Platform: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Offline Platform
    • 9.4.1 Overview
    • 9.4.2 Offline Platform: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 Asia Pacific Direct-to-Consumer Genetic Testing Market, by Key Country - Revenue (2022) (US$ Million)
    • 10.1.1 Asia Pacific Direct-to-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
      • 10.1.1.1 China: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.2 China: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2 China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.2.3 China: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.3 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.4 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.4.2 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.4.3 Japan: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.5 India: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.6 India: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.6.2 India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.6.3 India: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.7 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.8 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.8.1 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.8.2 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.8.3 Australia: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.9 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.10 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.10.1 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.10.2 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.10.3 South Korea: Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.11 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.12 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.12.1 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.12.2 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.12.3 Rest of Asia Pacific Direct-to-Consumer Genetic Testing Market, by Distribution Channel, 2020-2030 (US$ Million)

11. Asia Pacific Direct-to-Consumer Genetic Testing Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Genesis Healthcare Co
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Ancestry Genomics Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Myriad Genetics, Inc.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Living DNA Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 23andMe Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Genetic Technologies Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms